Pictet Asset Management Holding Sa Vaxcyte, Inc. Transaction History
Pictet Asset Management Holding Sa
- $88 Billion
- Q3 2024
A detailed history of Pictet Asset Management Holding Sa transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 780,905 shares of PCVX stock, worth $69.1 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
780,905
Previous 532,904
46.54%
Holding current value
$69.1 Million
Previous $40.2 Million
121.56%
% of portfolio
0.1%
Previous 0.05%
Shares
5 transactions
Others Institutions Holding PCVX
# of Institutions
352Shares Held
122MCall Options Held
775KPut Options Held
433K-
Vanguard Group Inc Valley Forge, PA11.4MShares$1.01 Billion0.02% of portfolio
-
Janus Henderson Group PLC London, X010.9MShares$967 Million0.67% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$880 Million0.02% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.69MShares$769 Million13.83% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.9MShares$434 Million0.12% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $5.25B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...